KR101874660B1 - 글루칸 - Google Patents

글루칸 Download PDF

Info

Publication number
KR101874660B1
KR101874660B1 KR1020137016830A KR20137016830A KR101874660B1 KR 101874660 B1 KR101874660 B1 KR 101874660B1 KR 1020137016830 A KR1020137016830 A KR 1020137016830A KR 20137016830 A KR20137016830 A KR 20137016830A KR 101874660 B1 KR101874660 B1 KR 101874660B1
Authority
KR
South Korea
Prior art keywords
glucan
gel
product
present
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020137016830A
Other languages
English (en)
Korean (ko)
Other versions
KR20130121137A (ko
Inventor
롤프 엔그스타드
돌 노크란드
Original Assignee
바이오텍 파마콘 에이에스에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바이오텍 파마콘 에이에스에이 filed Critical 바이오텍 파마콘 에이에스에이
Publication of KR20130121137A publication Critical patent/KR20130121137A/ko
Application granted granted Critical
Publication of KR101874660B1 publication Critical patent/KR101874660B1/ko
Assigned to 바이오텍 베타글루칸스 에이에스 reassignment 바이오텍 베타글루칸스 에이에스 권리의 전부이전등록 Assignors: 아크틱자임즈 테크놀러지스 에이에스에이
Assigned to 단스타 퍼멘트 에이쥐 reassignment 단스타 퍼멘트 에이쥐 권리의 전부이전등록 Assignors: 바이오텍 베타글루칸스 에이에스
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020137016830A 2010-11-29 2011-11-29 글루칸 Active KR101874660B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1020190.3 2010-11-29
GBGB1020190.3A GB201020190D0 (en) 2010-11-29 2010-11-29 Glucans
PCT/GB2011/052357 WO2012073018A1 (en) 2010-11-29 2011-11-29 Glucans

Publications (2)

Publication Number Publication Date
KR20130121137A KR20130121137A (ko) 2013-11-05
KR101874660B1 true KR101874660B1 (ko) 2018-08-02

Family

ID=43500782

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137016830A Active KR101874660B1 (ko) 2010-11-29 2011-11-29 글루칸

Country Status (9)

Country Link
US (2) US9623043B2 (cg-RX-API-DMAC7.html)
EP (1) EP2646475B1 (cg-RX-API-DMAC7.html)
JP (1) JP5932824B2 (cg-RX-API-DMAC7.html)
KR (1) KR101874660B1 (cg-RX-API-DMAC7.html)
CN (1) CN103347900B (cg-RX-API-DMAC7.html)
CA (1) CA2818584C (cg-RX-API-DMAC7.html)
DK (1) DK2646475T3 (cg-RX-API-DMAC7.html)
GB (1) GB201020190D0 (cg-RX-API-DMAC7.html)
WO (1) WO2012073018A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT6145B (lt) 2014-04-14 2015-04-27 Uab "Biocentras" TERAPINĖ ß-GLIUKANŲ KOMPOZICIJA, MODULIUOJANTI ŽMOGAUS IMUNINĘ SISTEMĄ IR INICIJUOJANTI VĖŽINIŲ LĄSTELIŲ ARDYMĄ
CN108939130A (zh) * 2017-05-21 2018-12-07 衢州玛济克医疗科技有限公司 一种褥疮医用敷料及其生产方法
CN108904859A (zh) * 2018-07-23 2018-11-30 衢州玛济克医疗科技有限公司 一种痔疮医用敷料及其生产方法
CN108837175A (zh) * 2018-07-23 2018-11-20 衢州玛济克医疗科技有限公司 一种清创医用敷料及其生产方法
US12223039B2 (en) * 2019-08-29 2025-02-11 Flexxon Pte Ltd Methods and systems using an AI co-processor to detect anomalies caused by malware in storage devices
US11384160B1 (en) 2021-07-30 2022-07-12 Tissue repair ltd Method of making a beta glucan compound
US11572420B1 (en) 2021-07-30 2023-02-07 Tissue repair ltd Isolated biological polysaccharide compound, methods of use and methods of manufacture thereof
CN114014949B (zh) * 2021-11-15 2022-08-30 戚春建 一种水溶性酵母葡聚糖的制备方法
CN116139039B (zh) * 2023-02-07 2026-01-02 北京安德普泰医疗科技有限公司 一种含有乳酸低刺激性的组合物及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090004201A1 (en) * 2006-01-17 2009-01-01 Rolf Einar Engstad Therapy-Enhancing Glucan
WO2009063221A2 (en) * 2007-11-13 2009-05-22 Biotec Pharmacon Asa Methods of treating or preventing inflammatory diseases of the intestinal tract

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082936A (en) 1984-11-28 1992-01-21 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
EP0490995A1 (en) 1989-09-08 1992-06-24 Alpha Beta Technology Method for producing soluble glucans
US5158772A (en) * 1991-09-23 1992-10-27 Davis Walter B Unique bacterial polysaccharide polymer gel in cosmetics, pharmaceuticals and foods
NO300692B1 (no) 1994-04-29 1997-07-07 Biotec Mackzymal As Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
US5980918A (en) 1997-10-24 1999-11-09 Brennen Medical, Inc. β-D-glucan topical composition
AU3657100A (en) 1999-03-12 2000-10-04 Biotec Asa Use of water-soluble beta-(1,3) glucans as agents for producing therapeutic skintreatment agents
DE10022095B4 (de) 2000-05-08 2005-07-14 Südzucker AG Mannheim/Ochsenfurt Gel aus einem Poly-α-1,4-Glucan und Stärke
DE60135658D1 (de) * 2000-07-03 2008-10-16 Granate Seed Ltd In kaltem wasser lösliches -g(b)-glukanprodukt und verfahren zu dessen herstellung
CA2434938C (en) 2001-01-16 2012-02-28 Sloan-Kettering Institute For Cancer Research Compositions of glucan and a monoclonal antibody which exhibit an enhancement of the anti tumor activity of the antibody
GB0225502D0 (en) 2002-11-01 2002-12-11 Zoolife Internat Ltd Therapeutic and prophylactic preparations
WO2006123173A1 (en) 2005-05-19 2006-11-23 Kilda Biolink As Gelatin-containing topical composition
EP1957168A2 (en) 2005-11-30 2008-08-20 Ciba Holding Inc. Glucan compositions
CN101426510A (zh) * 2006-01-17 2009-05-06 斯隆-凯特林癌症研究院 增强治疗的酵母葡聚糖
WO2008102151A1 (en) 2007-02-21 2008-08-28 Biotec Pharmacon Asa Medical uses of glucans
CZ303471B6 (cs) 2007-10-03 2012-10-03 Contipro Biotech S.R.O. Prípravek pro hojení ran a prevenci adheze bandáže na ránu obsahující chitosan-glukan
US20120288495A1 (en) * 2009-07-22 2012-11-15 Biothera, Inc. Therapeutic compositions and methods

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090004201A1 (en) * 2006-01-17 2009-01-01 Rolf Einar Engstad Therapy-Enhancing Glucan
WO2009063221A2 (en) * 2007-11-13 2009-05-22 Biotec Pharmacon Asa Methods of treating or preventing inflammatory diseases of the intestinal tract

Also Published As

Publication number Publication date
DK2646475T3 (en) 2017-02-27
CA2818584C (en) 2016-11-15
CN103347900A (zh) 2013-10-09
US20170056433A1 (en) 2017-03-02
WO2012073018A1 (en) 2012-06-07
US9623043B2 (en) 2017-04-18
US20130310338A1 (en) 2013-11-21
JP5932824B2 (ja) 2016-06-08
EP2646475A1 (en) 2013-10-09
CN103347900B (zh) 2016-06-01
GB201020190D0 (en) 2011-01-12
KR20130121137A (ko) 2013-11-05
JP2014503621A (ja) 2014-02-13
EP2646475B1 (en) 2017-01-25
US10646506B2 (en) 2020-05-12
CA2818584A1 (en) 2012-06-07

Similar Documents

Publication Publication Date Title
US9956245B2 (en) Glucan compositions
US10646506B2 (en) Glucans
US9750688B2 (en) Glucan gels
AU2013203451B8 (en) Glucan Gels

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 8